Literature DB >> 12583918

MYO2 is not essential for viability, but is required for polarized growth and dimorphic switches in Candida albicans.

Miyoung Woo1, Kyunghee Lee, Kiwon Song.   

Abstract

The human fungal pathogen Candida albicans changes from a budding yeast form to a polarized hyphal form in response to various external conditions. Dimorphic switching of C. albicans has been implicated in the development of pathogenicity. Morphogenic transformation requires polarized cell growth and rearrangement of the cytoskeleton. We previously showed that myosins play key roles in the conversion from the bud to the hyphal form of C. albicans by inhibiting myosin activities with 2,3-butanedione-2-monoxime (BDM), a general myosin ATPase inhibitor. In this study we investigated the function of MYO2 in C. albicans using deletion mutants. The amino acid sequence of CaMYO2 shows 60% identity and 77% homology with MYO2 and 54% identity and 70% homology with MYO4 of budding yeast Saccharomyces cerevisiae, suggesting that CaMYO2 is the only class V myosin in C. albicans. Cells in which both CaMYO2 alleles were deleted were viable, suggesting that MYO2 is nonessential in C. albicans. The proliferation of CaMYO2delta cells, however, was sharply decreased. In addition, CaMYO2delta cells showed defects in assembly and polarized localization of F-actin as well as an inability to induce germ tube formation and hyphal growth. The deletion of CaMYO2 also disrupted the shape and migration of the nucleus. These results strongly suggest that CaMYO2 is essential for polarized growth and hyphal transition in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12583918     DOI: 10.1111/j.1574-6968.2003.tb11518.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  Functional characterization of myosin I tail regions in Candida albicans.

Authors:  Ursula Oberholzer; Tatiana L Iouk; David Y Thomas; Malcolm Whiteway
Journal:  Eukaryot Cell       Date:  2004-10

Review 2.  Actin organization and dynamics in filamentous fungi.

Authors:  Adokiye Berepiki; Alexander Lichius; Nick D Read
Journal:  Nat Rev Microbiol       Date:  2011-11-02       Impact factor: 60.633

3.  Transcript profiles of Candida albicans cortical actin patch mutants reflect their cellular defects: contribution of the Hog1p and Mkc1p signaling pathways.

Authors:  Ursula Oberholzer; André Nantel; Judith Berman; Malcolm Whiteway
Journal:  Eukaryot Cell       Date:  2006-08

Review 4.  Hyphal growth: a tale of motors, lipids, and the Spitzenkörper.

Authors:  Gero Steinberg
Journal:  Eukaryot Cell       Date:  2007-01-26

5.  Disruption of actin motor function due to MoMyo5 mutation impairs host penetration and pathogenicity in Magnaporthe oryzae.

Authors:  Wei Tang; Chuyun Gao; Jingzhen Wang; Ziyi Yin; Jinlong Zhang; Jun Ji; Haifeng Zhang; Xiaobo Zheng; Zhengguang Zhang; Ping Wang
Journal:  Mol Plant Pathol       Date:  2017-06-02       Impact factor: 5.663

Review 6.  Messenger RNA transport in the opportunistic fungal pathogen Candida albicans.

Authors:  Anne E McBride
Journal:  Curr Genet       Date:  2017-05-16       Impact factor: 3.886

Review 7.  mRNA trafficking in fungi.

Authors:  Kathi Zarnack; Michael Feldbrügge
Journal:  Mol Genet Genomics       Date:  2007-09-01       Impact factor: 3.291

8.  Distinct Roles of Myosins in Aspergillus fumigatus Hyphal Growth and Pathogenesis.

Authors:  Hilary Renshaw; José M Vargas-Muñiz; Amber D Richards; Yohannes G Asfaw; Praveen R Juvvadi; William J Steinbach
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization.

Authors:  Kristy Dolan; Sara Montgomery; Bradley Buchheit; Louis Didone; Melanie Wellington; Damian J Krysan
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

10.  An RNA transport system in Candida albicans regulates hyphal morphology and invasive growth.

Authors:  Sarah L Elson; Suzanne M Noble; Norma V Solis; Scott G Filler; Alexander D Johnson
Journal:  PLoS Genet       Date:  2009-09-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.